Viewing Study NCT00391092


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-01-04 @ 11:01 AM
Study NCT ID: NCT00391092
Status: COMPLETED
Last Update Posted: 2015-08-28
First Post: 2006-10-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
Sponsor:
Organization: